Domů › Nemalobuněčný plicní karcinom › Illinois › Evanston
Klinické studie Nemalobuněčný plicní karcinom v Evanston, IL
22 studií pro Nemalobuněčný plicní karcinom hledá účastníky v lokalitách v Evanston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Probíhá náborFáze 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · Vzdálenost 5 mi
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
- a dalších 1
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Probíhá náborFáze 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Probíhá náborFáze 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Probíhá náborFáze 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Illinois Cancer Specialists, Niles · Vzdálenost 6 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Probíhá náborFáze 3
- Illinois Cancer Specialists, Niles · Vzdálenost 6 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Probíhá náborFáze 3
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- Illinois Cancer Specialists /ID# 274678, Niles · Vzdálenost 6 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Probíhá náborFáze 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Probíhá náborFáze 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · Vzdálenost 6 mi
- Advocate Medical Group Oncology, Park Ridge · Vzdálenost 8 mi
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Probíhá náborObservační studie
- Orchard Healthcare Research Inc., Skokie · Vzdálenost 2 mi
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Probíhá náborFáze 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · Vzdálenost 2 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Probíhá náborFáze 3
- Research Site, Niles · Vzdálenost 6 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Probíhá náborFáze 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Probíhá náborFáze 2
- Advocate Aurora Health, Park Ridge · Vzdálenost 8 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Vzdálenost 5 mi
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Advocate Lutheran General Hospital, Park Ridge · Vzdálenost 8 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Probíhá náborObservační studie
- Northwestern University, Evanston
Studie Nemalobuněčný plicní karcinom v jiných městech
- Houston, TX145 studií
- New York City, NY120 studií
- Arlington, VA104 studií
- Nashville, TN97 studií
- Boston, MA90 studií
- Los Angeles, CA87 studií
- St. Louis, MO73 studií
- Chicago, IL61 studií
- Baltimore, MD60 studií
- San Antonio, TX59 studií
- Columbus, OH56 studií
- Washington, DC55 studií
Další studie v Evanston
- Rakovina plic19 studií
- Rakovina prsu13 studií
- Akutní myeloidní leukemie11 studií
- Obesity11 studií
- Kolorektální karcinom10 studií
- Rakovina (všechny typy)9 studií
- Nadváha9 studií
- Ulcerózní kolitida9 studií
- Rakovina prostaty9 studií
- Crohnova choroba9 studií
- Srdeční selhání8 studií
- Síňová fibrilace8 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.